ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid

ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid

We describe simple, sensitive and robust methods to monitor lipoprotein remodeling and cholesterol and apolipoprotein exchange, using fluorescent Lissamine Rhodamine B head-group tagged phosphatidylethanolamine (*PE) as a lipoprotein reference marker. Fluorescent Bodipy cholesterol (*Chol) and *PE d...

Full description

Bibliographic Details
Main Authors:	Edward B. Neufeld, Masaki Sato, Scott M. Gordon, Vinay Durbhakula, Nicolas Francone, Angel Aponte, Gizem Yilmaz, Denis Sviridov, Maureen Sampson, Jingrong Tang, Milton Pryor, Alan T. Remaley
Format:	Article
Language:	English
Published:	MDPI AG 2019-07-01
Series:	Biology
Subjects:	phospholipids/phosphatidylethanolamine cholesterol/efflux apolipoproteins HDL (High-density lipoprotein)/metabolism lipoproteins mass spectrometry membranes/model low-density lipoprotein (LDL)
Online Access:	https://www.mdpi.com/2079-7737/8/3/53

Similar Items

Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
by: Shucun Qin, et al.
Published: (2000-02-01)

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution
by: Susan J. Murdoch, et al.
Published: (2002-08-01)

Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
by: Oktawia Nilsson, et al.
Published: (2021-01-01)

SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
by: Maria C. de Beer, et al.
Published: (2005-10-01)

Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein
by: Nongnuch Settasatian, et al.
Published: (2008-01-01)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
by: Kyung-Hyun Cho
Published: (2022-04-01)

High-Density Lipoprotein Suppresses Neutrophil Extracellular Traps Enhanced by Oxidized Low-Density Lipoprotein or Oxidized Phospholipids
by: Hitomi Ohinata, et al.
Published: (2022-11-01)

Beneficial Effect of Cuban Policosanol on Blood Pressure and Serum Lipoproteins Accompanied with Lowered Glycated Hemoglobin and Enhanced High-Density Lipoprotein Functionalities in a Randomized, Placebo-Controlled, and Double-Blinded Trial with Healthy Japanese
by: Kyung-Hyun Cho, et al.
Published: (2023-03-01)

Serum lipid profile in patients with primary fibromyalgia
by: Enas J. Kaoud, et al.
Published: (2011-04-01)

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]
by: Fabiana Rached, et al.
Published: (2014-12-01)

Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells
by: John F. Oram, et al.
Published: (1999-10-01)

Strategies for consistent and automated quantification of HDL proteome using data-independent acquisition
by: Douglas Ricardo Souza Junior, et al.
Published: (2023-07-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

Physiology Dept, School of Medicine, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran
by: M FESHARAKI
Published: (2001-09-01)

Assessment of lipid abnormalities and Cardiovascular Risk indices in Type 2 Diabetes Mellitus
by: Sushil Baral, et al.
Published: (2019-10-01)

Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population
by: Tara R. Price, et al.
Published: (2023-12-01)

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I*
by: Brian J. Van Lenten, et al.
Published: (2008-11-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

Interrelationship between rat serum very low density and high density lipoproteins
by: Bernard Rubenstein, et al.
Published: (1972-05-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)

The Regulation of Fat Metabolism during Aerobic Exercise
by: Antonella Muscella, et al.
Published: (2020-12-01)

Human apoA-I[Lys107del] mutation affects lipid surface behavior of apoA-I and its ability to form large nascent HDL
by: Irina N. Gorshkova, et al.
Published: (2023-02-01)

Characterization and properties of preβ-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I*
by: Phu T. Duong, et al.
Published: (2008-05-01)

Cholesterol in Human Body: Importance and Dosage
by: Florentina GÎRBOIU, et al.
Published: (2023-12-01)

Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement
by: Susan J. Murdoch, et al.
Published: (2002-02-01)

PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity
by: Daoguang Yan, et al.
Published: (2004-10-01)

Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels
by: Omar L. Francone, et al.
Published: (2011-11-01)

Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects
by: Takayuki Sasahara, et al.
Published: (1998-03-01)

Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01)

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II
by: Uli C. Broedl, et al.
Published: (2006-10-01)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
by: Bi-lian Yu, et al.
Published: (2012-09-01)

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
by: Alexander R. Berg, et al.
Published: (2023-02-01)

Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins
by: Sylwia Płaczkowska, et al.
Published: (2022-05-01)

Lipid Biomarkers in Depression: Does Antidepressant Therapy Have an Impact?
by: Fidelis Christin Stuchtey, et al.
Published: (2022-02-01)

Dairy products and plasma cholesterol levels
by: Lena Ohlsson
Published: (2010-08-01)

Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor
by: Danijela Lucic, et al.
Published: (2007-02-01)

Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein
by: Paul Rava, et al.
Published: (2005-08-01)

Lipoprotein particles exhibit distinct mechanical properties
by: Melissa C. Piontek, et al.
Published: (2022-12-01)